https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
Patients with inflammatory neuropathies should be encouraged to adhere to the vaccination campaign for COVID-19. These recommendations provide guidance on the management of vaccinations for COVID-19 in patients with inflammatory neuropathies. More research is needed regarding the safety and efficacy of vaccination in patients with inflammatory neuropathies and other immune conditions. Patients with inflammatory neuropathies should be encouraged to adhere to the vaccination campaign for COVID-19. These recommendation
Like
Comment
Share
